It did not have a significantly different therapeutic efficacy from the commercial paste dosage form in the treatment of oral lichen planus. Buffering agents and an antioxidant should be added to ...

Statistically significant safety and efficacy data from 0.25 mg and 0.50 mg cohorts to be presented Presentation scheduled ...

This is known as the isomorphic response or Koebner phenomena. Varients of lichen planus are presented in Figures 2-9. Treatment: There is no cure for lichen planus but treatment often relieves ...

for the treatment of oral lichen planus (OLP). The Company also recently reported full enrollment across all three planned dose cohorts. Treatment with LP-310 at the 0.50 mg dose demonstrated ...

Michael Chancellor, Co-Founder and Chief Medical Officer of Lipella Pharmaceuticals. “Oral lichen planus is a painful, chronic condition with no FDA-approved treatment and limited therapeutic options.

“Oral lichen planus is a painful, chronic condition with no FDA-approved treatment and limited therapeutic options. The symptom relief reported by patients, along with reductions in inflammation ...

“Oral lichen planus is a painful, chronic condition with no FDA-approved treatment and limited therapeutic options. The symptom relief reported by patients, along with reductions in inflammation ...

Michael Chancellor, Chief Medical Officer and Co-Founder of Lipella Pharmaceuticals. "These findings support LP-310's potential as a localized, non-steroidal treatment for Oral Lichen Planus. We look ...

Considering taking supplements to treat lichen sclerosus? Below is a list of common natural remedies used to treat or reduce the symptoms of lichen sclerosus. Follow the links to read common uses ...